<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/413237</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;413237</article-id><article-id pub-id-type="other" hwp:sub-type="slug">413237</article-id><article-id pub-id-type="other" hwp:sub-type="tag">413237</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Pharmacology" hwp:journal="biorxiv"><subject>Pharmacology and Toxicology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Primary Target Prediction of Bioactive Molecules from Chemical Structure</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label>To whom correspondence should be addressed. Tel: (+9821) 22400080; Fax: (+9821) 22400568; Email: <email hwp:id="email-1">ssamadi@alumni.ut.ac.ir</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Forouzesh Abed"><surname>Forouzesh</surname><given-names>Abed</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Foroushani Sadegh Samadi"><surname>Foroushani</surname><given-names>Sadegh Samadi</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Forouzesh Fatemeh"><surname>Forouzesh</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Zand Eskandar"><surname>Zand</surname><given-names>Eskandar</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3"><label>1</label><institution hwp:id="institution-1">Iranian Research Institute of Plant Protection, Agricultural Research Education and Extension Organization (AREEO)</institution>, Tehran, <country>Iran</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1"><label>2</label><institution hwp:id="institution-2">Department of Medicine, Tehran Medical Branch, Islamic Azad University</institution>, Tehran, <country>Iran</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2018"><year>2018</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-09-10T06:15:11-07:00">
    <day>10</day><month>9</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2018-09-10T06:15:11-07:00">
    <day>10</day><month>9</month><year>2018</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-09-10T06:22:22-07:00">
    <day>10</day><month>9</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2018-09-10T06:22:22-07:00">
    <day>10</day><month>9</month><year>2018</year>
  </pub-date><elocation-id>413237</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-09-10"><day>10</day><month>9</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2018-09-10"><day>10</day><month>9</month><year>2018</year></date>
<date date-type="accepted" hwp:start="2018-09-10"><day>10</day><month>9</month><year>2018</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2018</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" hwp:id="license-1"><p hwp:id="p-1">This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></p></license></permissions><self-uri xlink:href="413237.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/413237v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="413237.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/413237v1/413237v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/413237v1/413237v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">There are various tools for computational target prediction of bioactive molecules from a chemical structure in a machine-readable material but these tools can’t distinguish a primary target from other targets. Also, due to the complex nature of bioactive molecules, there has not been a method to predict a target and or a primary target from a chemical structure in a non-digital material (for example printed or hand-written documents) yet. In this study, an attempt to simplify primary target prediction from a chemical structure was resulted in developing an innovative method based on the minimum structure which can be used in both formats of non-digital and machine-readable materials. A minimum structure does not represent a real molecule or a real association of functional groups, but is a part of a molecular structure which is necessary to ensure the primary target prediction of bioactive molecules. Structurally related bioactive molecules with the minimum structure were considered as neighbor molecules of the query molecule. The known primary target of the neighbor molecule is used as a reference for predicting the primary target of the neighbor molecule with an unknown primary target. In results, we confirmed the usefulness of our proposed method for primary target prediction in 548 drugs and pesticides involved in four primary targets by eight minimum structures.</p></abstract><counts><page-count count="30"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">INTRODUCTION</title><p hwp:id="p-3">Bioactive molecules such as drugs and pesticides are produced in large numbers by many commercial and academic groups around the world<sup><xref rid="c18" ref-type="bibr" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref></sup>. Most bioactive molecules perform their actions by interacting with proteins or other macromolecules<sup><xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref></sup>. However, for a significant fraction of them, the primary target remains unknown<sup><xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-2" hwp:rel-id="ref-5">5</xref></sup>.</p><p hwp:id="p-4">Computer-aided drug design, that offers an <italic toggle="yes">in silico</italic> alternative to medicinal and agricultural chemistry techniques for studying the structure and predicting the biological activity of drug and pesticide candidates, has the advantages of both speed and low cost and is becoming an indispensable program of major pharmaceutical and agrochemical companies<sup><xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref></sup>.</p><p hwp:id="p-5">With the ever-increasing public availability of bioactivity data<sup><xref rid="c2" ref-type="bibr" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref></sup>, it is possible to construct reliable target prediction models using statistical or machine learning methods<sup><xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref></sup>. However, bioactivity data hasn’t been increased in all areas. For example, the databases are rich in human targets and molecules that modulate these targets, but contain limited information when it comes to bacterial targets<sup><xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref></sup>.</p><p hwp:id="p-6">Various methods (such as chemical structure similarity searching<sup><xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref></sup>, data mining/machine learning<sup><xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref></sup>, panel docking<sup><xref rid="c14" ref-type="bibr" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref></sup> and bioactivity spectra based algorithms<sup><xref rid="c3" ref-type="bibr" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref></sup>) can be employed for computational target prediction (each method adopts a particular model type). The tools created by these methods have not been able to distinguish between a primary target and other targets yet due to the focus of databases from which they have been extracted. Also, they are not equally reliable in all areas. Furthermore, chemical structures should be provided in machine-readable descriptions so that the tools can be used.</p><p hwp:id="p-7">Based on our knowledge, there is no method to predict a target and or a primary target from a chemical structure in a non-digital material. In this study, an attempt to simplify primary target prediction from a chemical structure was resulted in developing an innovative method based on the minimum structure which can be used in both formats of non-digital and machine-readable materials. The proposed method has several distinctive features compared to available computational target prediction methods. Firstly, it’s easy to use. Secondly, it is highly accurate. Thirdly, it can be used appropriately in both formats of non-digital and machine-readable materials. Fourthly, it enables us to gain a deeper understanding (more informative) of the relationship between the chemical structure and the primary target.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-3">METHODS</title><p hwp:id="p-8">The proposed method steps for primary target prediction of bioactive molecules from a chemical structure include (i) query molecule, (ii) similarity searching, (iii) data collection, (iv) minimum structure identification and (v) primary target prediction (example in <xref rid="figS9" ref-type="fig" hwp:id="xref-fig-9-1" hwp:rel-id="F9">Supplementary Figure 9</xref>).</p><sec id="s2a" hwp:id="sec-3"><label>(I)</label><title hwp:id="title-4">Query molecule</title><p hwp:id="p-9">A bioactive molecule such as a drug or a pesticide is used as a query molecule. The query molecule may have a known or an unknown primary target. The query molecule with known primary target can be used as a reference to predict the primary target of structurally related bioactive molecules.</p></sec><sec id="s2b" hwp:id="sec-4"><label>(II)</label><title hwp:id="title-5">Similarity searching</title><p hwp:id="p-10">The query molecule is used to search for the structurally related bioactive molecules with similar chemical scaffold. However, it must be born in mind that structurally related analogs may bind in a slightly or considerably different manner<sup><xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref></sup>. KEGG<sup><xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref></sup>, DrugBank<sup><xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup>, PubChem<sup><xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref></sup> and ChEMBL<sup><xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref></sup> databases provide common names and chemical structures for large numbers of bioactive molecules and, in some cases, their primary targets. All four databases support structure similarity searches.</p></sec><sec id="s2c" hwp:id="sec-5"><label>(III)</label><title hwp:id="title-6">Data collection</title><p hwp:id="p-11">The primary target information is collected for all structurally related bioactive molecules. If the primary target of the query molecule is not known, information on structure-activity relationship and pharmacophore will be collected for all structurally related bioactive molecules. If the primary target of the query molecule is known, information on structure-activity relationship and pharmacophore will be collected only for structurally related bioactive molecules with the same primary target as the query molecule.</p><p hwp:id="p-12">Information on the primary target, structure-activity relationship and pharmacophore are obtained from databases with annotated primary target (such as KEGG<sup><xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref></sup>, DrugBank<sup><xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">23</xref></sup>, PubChem<sup><xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref></sup> and ChEMBL<sup><xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-2" hwp:rel-id="ref-4">4</xref></sup> databases), scientific literature and pharmacophoric descriptors (including hydrogen bonds, hydrophobic and electrostatic interaction sites). The most recent development regarding pharmacophore alignment technique is LigandScout’s pattern matching approach<sup><xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref></sup>.</p></sec><sec id="s2d" hwp:id="sec-6"><label>(IV)</label><title hwp:id="title-7">Minimum structure identification</title><p hwp:id="p-13">A minimum structure does not represent a real molecule or a real association of functional groups, but is a part of a molecular structure which is necessary to ensure the primary target prediction of bioactive molecules. The minimum structure is identified using data collection about the structurally related bioactive molecules. The minimum structure consists of the core and or the peripheral part. Here, the peripheral part is shown as the comment. The core plays an essential role in a bioactive molecule. Furthermore, modifying at some key position on the peripheral part can make a big change in the primary target or the activity of a bioactive molecule. Thus, the peripheral part can be useful for distinguishing the bioactive molecules based on their primary targets.</p><p hwp:id="p-14">Since the minimum structure is related to the structurally related bioactive molecules and information about them, when they become available, the minimum structure can be updated to further refine it.</p></sec><sec id="s2e" hwp:id="sec-7"><label>(V)</label><title hwp:id="title-8">Primary target prediction</title><p hwp:id="p-15">Structurally related bioactive molecules with the minimum structure were considered as neighbor molecules of the query molecule. The known primary target of the neighbor molecule is used as a reference for predicting the primary target of the neighbor molecule with an unknown primary target.</p></sec></sec><sec id="s3" hwp:id="sec-8"><title hwp:id="title-9">RESULTS AND DISCUSSION</title><p hwp:id="p-16">In results, we made predictions for eight groups of bioactive molecules. Here, the proposed method was employed in 548 drugs and pesticides involved in four primary targets (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Tables 1</xref>-4 and Supplementary Data 1). 4-Pyridone group includes 192 bioactive molecules of DNA gyrase and topoisomerase IV inhibitors (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>; example in <xref rid="figS1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Supplementary Figure 1</xref>), 2,4(or 5)-diaminocyclohexanol group includes 138 bioactive molecules of small ribosomal subunit inhibitors (<xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref>; example in <xref rid="figS2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Supplementary Figure 2</xref>), (4a<italic toggle="yes">RS</italic>,5a<italic toggle="yes">RS</italic>)-Sancycline group includes 34 bioactive molecules of small ribosomal subunit inhibitors (<xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2">Table 2</xref>; example in <xref rid="figS3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Supplementary Figure 3</xref>), cytosine group includes 28 bioactive molecules of large ribosomal subunit inhibitors (<xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Table 3</xref>; example in <xref rid="figS4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Supplementary Figure 4</xref>), 3-glutarimidyl group includes 17 bioactive molecules of large ribosomal subunit inhibitors (<xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-2" hwp:rel-id="T3">Table 3</xref>; example in <xref rid="figS5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Supplementary Figure 5</xref>), (1<italic toggle="yes">R</italic>)-propanol group includes 10 bioactive molecules of large ribosomal subunit inhibitors (<xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-3" hwp:rel-id="T3">Table 3</xref>; example in <xref rid="figS6" ref-type="fig" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Supplementary Figure 6</xref>), imidazol-1-yl group includes 54 bioactive molecules of sterol 14α-demethylase inhibitors (<xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-1" hwp:rel-id="T4">Table 4</xref>; example in <xref rid="figS7" ref-type="fig" hwp:id="xref-fig-7-1" hwp:rel-id="F7">Supplementary Figure 7</xref>), and 1,2,4-triazol-1-yl group includes 75 bioactive molecules of sterol 14α-demethylase inhibitors (<xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-2" hwp:rel-id="T4">Table 4</xref>; example in <xref rid="figS8" ref-type="fig" hwp:id="xref-fig-8-1" hwp:rel-id="F8">Supplementary Figure 8</xref>).</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><p hwp:id="p-17">The bioactive molecules with primary target of bacterial type IIA topoisomerase (DNA gyrase and topoisomerase IV) inhibition predicted by the minimum structure.</p></caption><graphic xlink:href="413237_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></table-wrap><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-2"><p hwp:id="p-18">The bioactive molecules with primary target of small ribosomal subunit inhibition predicted by the minimum structure.</p></caption><graphic xlink:href="413237_tbl2" position="float" orientation="portrait" hwp:id="graphic-2"/></table-wrap><table-wrap id="tbl3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1 xref-table-wrap-3-2 xref-table-wrap-3-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/TBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tbl3</object-id><label>Table 3.</label><caption hwp:id="caption-3"><p hwp:id="p-19">The bioactive molecules with primary target of large ribosomal subunit inhibition predicted by the minimum structure.</p></caption><graphic xlink:href="413237_tbl3" position="float" orientation="portrait" hwp:id="graphic-3"/></table-wrap><table-wrap id="tbl4" orientation="portrait" position="float" hwp:id="T4" hwp:rev-id="xref-table-wrap-4-1 xref-table-wrap-4-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/TBL4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tbl4</object-id><label>Table 4.</label><caption hwp:id="caption-4"><p hwp:id="p-20">The bioactive molecules with primary target of sterol 14α-demethylase inhibition predicted by the minimum structure.</p></caption><graphic xlink:href="413237_tbl4" position="float" orientation="portrait" hwp:id="graphic-4"/></table-wrap><p hwp:id="p-21">Many of these 548 predictions were either confirmed by scientific literature, database searching or computational target prediction tools. Out of 548 predictions, 371 predictions (67.7%) were confirmed by scientific literature published in scientific journals, conferences and books (4-pyridone group with 24.5%, 1,2,4-triazol-1-yl group with 11.3%, 2,4(or 5)-diaminocyclohexanol group with 11.3%, imidazol-1-yl group with 6.9%, (4a<italic toggle="yes">RS</italic>,5a<italic toggle="yes">RS</italic>)-Sancycline group with 4.7%, cytosine group with 4.6%, 3-glutarimidyl group with 2.7% and (1<italic toggle="yes">R</italic>)-propanol group with 1.6%; Supplementary Data 2), 160 predictions (29.2%) were confirmed by database searching (KEGG<sup><xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-3" hwp:rel-id="ref-7">7</xref></sup>, PubChem<sup><xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-3" hwp:rel-id="ref-10">10</xref></sup>, DrugBank<sup><xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-3" hwp:rel-id="ref-23">23</xref></sup> and ChEMBL<sup><xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-3" hwp:rel-id="ref-4">4</xref></sup> respectively with 23.2%, 16.4%, 11.3% and 10.4%; Supplementary Data 3) for annotated primary target, 546 predictions (99.6%) were confirmed by computational target prediction tools (PASS online<sup><xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref></sup> with 99.3%, SEA<sup><xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref></sup> with 58%, PPB<sup><xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref></sup> with 54.4%, TargetHunter<sup><xref rid="c20" ref-type="bibr" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref></sup> with 44.7%, ChemProt<sup><xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref></sup> with 44.5%, PharmMapper<sup><xref rid="c22" ref-type="bibr" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref></sup> with 37.8%, SuperPred<sup><xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref></sup> with 8.6%, HitPick<sup><xref rid="c15" ref-type="bibr" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref></sup> with 6.4% and SPiDER<sup><xref rid="c19" ref-type="bibr" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref></sup> with 0.4%; Supplementary Data 4). We found no precedent for one prediction.</p><p hwp:id="p-22">A lot of information is needed to identify the minimum structure because it is necessary to know which part(s) of the bioactive molecule confers the activity. Therefore, the proposed method leads to a high accuracy and a deeper understanding of the relationship between the chemical structure and the primary target. Furthermore, after identifying the minimum structure, it’s been easy to use and it can be used in both formats of non-digital and machine-readable materials. Due to the complex nature of bioactive molecules, there has not been a method to predict a target and or a primary target from a chemical structure in a non-digital material yet and the proposed method is the only method that can be used for this purpose.</p><p hwp:id="p-23">The proposed method is not applicable in cases where no neighbor bioactive molecules for a primary target exist, since in these situations no training on the minimum structure-based information is possible.</p></sec></body><back><ref-list hwp:id="ref-list-1"><title hwp:id="title-10">REFERENCES</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Awale M."><surname>Awale</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Reymond J. L."><surname>Reymond</surname>, <given-names>J. L.</given-names></string-name> <article-title hwp:id="article-title-2">The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data</article-title>. <source hwp:id="source-1">J. cheminform</source>. <volume>9</volume>, <fpage>11</fpage> (<year>2017</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Bento A. P."><surname>Bento</surname>, <given-names>A. P.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-3">The ChEMBL bioactivity database: an update</article-title>. <source hwp:id="source-2">Nucleic Acids Res</source>. <volume>42</volume>, <fpage>D1083</fpage>–<lpage>D1090</lpage> (<year>2014</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Cheng T."><surname>Cheng</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li Q."><surname>Li</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang Y."><surname>Wang</surname>, <given-names>Y.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Bryant S. H."><surname>Bryant</surname>, <given-names>S. H.</given-names></string-name> <article-title hwp:id="article-title-4">Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining</article-title>. <source hwp:id="source-3">J. Chem. Inf. Model</source>. <volume>51</volume>, <fpage>2440</fpage>–<lpage>2448</lpage> (<year>2011</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1 xref-ref-4-2 xref-ref-4-3"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Gaulton A."><surname>Gaulton</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-5">The ChEMBL database in 2017</article-title>. <source hwp:id="source-4">Nucleic Acids Res</source>. <volume>45</volume>, <fpage>D945</fpage>–<lpage>D954</lpage> (<year>2017</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1 xref-ref-5-2"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Gfeller D."><surname>Gfeller</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Michielin O."><surname>Michielin</surname>, <given-names>O.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Zoete V."><surname>Zoete</surname>, <given-names>V.</given-names></string-name> <article-title hwp:id="article-title-6">Shaping the interaction landscape of bioactive molecules</article-title>. <source hwp:id="source-5">Bioinformatics</source> <volume>29</volume>, <fpage>3073</fpage>–<lpage>3079</lpage> (<year>2013</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Huang H. J."><surname>Huang</surname>, <given-names>H. J.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-7">Current developments of computer-aided drug design</article-title>. <source hwp:id="source-6">J. Taiwan Inst. Chem. Eng</source>. <volume>41</volume>, <fpage>623</fpage>–<lpage>635</lpage> (<year>2010</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2 xref-ref-7-3"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Kanehisa M."><surname>Kanehisa</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Furumichi M."><surname>Furumichi</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tanabe M."><surname>Tanabe</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sato Y."><surname>Sato</surname>, <given-names>Y.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Morishima K."><surname>Morishima</surname>, <given-names>K.</given-names></string-name> <article-title hwp:id="article-title-8">KEGG: new perspectives on genomes, pathways, diseases and drugs</article-title>. <source hwp:id="source-7">Nucleic Acids Res</source>. <volume>45</volume>, <fpage>D353</fpage>–<lpage>D361</lpage> (<year>2017</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Keiser M. J."><surname>Keiser</surname>, <given-names>M. J.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-9">Relating protein pharmacology by ligand chemistry</article-title>. <source hwp:id="source-8">Nat. Biotechnol</source>. <volume>25</volume>, <fpage>197</fpage>–<lpage>206</lpage> (<year>2007</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Keiser M. J."><surname>Keiser</surname>, <given-names>M. J.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-10">Predicting new molecular targets for known drugs</article-title>. <source hwp:id="source-9">Nature</source> <volume>462</volume>, <fpage>175</fpage>–<lpage>181</lpage> (<year>2009</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2 xref-ref-10-3"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Kim S."><surname>Kim</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-11">PubChem substance and compound databases</article-title>. <source hwp:id="source-10">Nucleic Acids Res</source>. <volume>44</volume>, <fpage>D1202</fpage>–<lpage>D1213</lpage> (<year>2016</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Koutsoukas A."><surname>Koutsoukas</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-12">From <italic toggle="yes">in silico</italic> target prediction to multi-target drug design: current databases, methods and applications</article-title>. <source hwp:id="source-11">J. Proteomics</source> <volume>74</volume>, <fpage>2554</fpage>–<lpage>2574</lpage> (<year>2011</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Kringelum J."><surname>Kringelum</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-13">ChemProt-3.0: a global chemical biology diseases mapping</article-title>. <source hwp:id="source-12">Database</source> <volume>2016</volume>, <fpage>bav123</fpage> (<year>2016</year>).</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Lagunin A."><surname>Lagunin</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stepanchikova A."><surname>Stepanchikova</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Filimonov D."><surname>Filimonov</surname>, <given-names>D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Poroikov V."><surname>Poroikov</surname>, <given-names>V.</given-names></string-name> <article-title hwp:id="article-title-14">PASS: prediction of activity spectra for biologically active substances</article-title>. <source hwp:id="source-13">Bioinformatics</source> <volume>16</volume>, <fpage>747</fpage>–<lpage>748</lpage> (<year>2000</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-15">TarFisDock: a web server for identifying drug targets with docking approach</article-title>. <source hwp:id="source-14">Nucleic Acids Res</source>. <volume>34</volume>, <fpage>W219</fpage>–<lpage>W224</lpage> (<year>2006</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Liu X."><surname>Liu</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vogt I."><surname>Vogt</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haque T."><surname>Haque</surname>, <given-names>T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Campillos M."><surname>Campillos</surname>, <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-16">HitPick: a web server for hit identification and target prediction of chemical screenings</article-title>. <source hwp:id="source-15">Bioinformatics</source> <volume>29</volume>, <fpage>1910</fpage>–<lpage>1912</lpage> (<year>2013</year>).</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Nickel J."><surname>Nickel</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-17">SuperPred: update on drug classification and target prediction</article-title>. <source hwp:id="source-16">Nucleic Acids Res</source>. <volume>42</volume>, <fpage>W26</fpage>–<lpage>W31</lpage> (<year>2014</year>).</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Nidhi ."><surname>Nidhi</surname>, <given-names>.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Glick M."><surname>Glick</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Davies J. W."><surname>Davies</surname>, <given-names>J. W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Jenkins J. L."><surname>Jenkins</surname>, <given-names>J. L.</given-names></string-name> <article-title hwp:id="article-title-18">Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases</article-title>. <source hwp:id="source-17">J. Chem. Inf. Model</source>. <volume>46</volume>, <fpage>1124</fpage>–<lpage>1133</lpage> (<year>2006</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Orchard S."><surname>Orchard</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-19">Minimum information about a bioactive entity (MIABE</article-title>). <source hwp:id="source-18">Nature Rev. Drug Discov</source>. <volume>10</volume>, <fpage>661</fpage>–<lpage>669</lpage> (<year>2011</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Reker D."><surname>Reker</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rodrigues T."><surname>Rodrigues</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schneider P."><surname>Schneider</surname>, <given-names>P.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Schneider G."><surname>Schneider</surname>, <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-20">Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus</article-title>. <source hwp:id="source-19">Proc. Natl. Acad. Sci. USA</source> <volume>111</volume>, <fpage>4067</fpage>–<lpage>4072</lpage> (<year>2014</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Wang L."><surname>Wang</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-21">TargetHunter: an <italic toggle="yes">in silico</italic> target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database</article-title>. <source hwp:id="source-20">AAPS J</source>. <volume>15</volume>, <fpage>395</fpage>–<lpage>406</lpage> (<year>2013</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Wang Z."><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liang L."><surname>Liang</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yin Z."><surname>Yin</surname>, <given-names>Z.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lin J."><surname>Lin</surname>, <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-22">Improving chemical similarity ensemble approach in target prediction</article-title>. <source hwp:id="source-21">J. Cheminform</source>. <volume>8</volume>, <fpage>1</fpage>–<lpage>10</lpage> (<year>2016</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Wang X."><surname>Wang</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-23">PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database</article-title>. <source hwp:id="source-22">Nucleic Acids Res</source>. <volume>45</volume>, <fpage>W356</fpage>–<lpage>W360</lpage> (<year>2017</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2 xref-ref-23-3"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Wishart D. S."><surname>Wishart</surname>, <given-names>D. S.</given-names></string-name> <etal>et al.</etal>. <article-title hwp:id="article-title-24">DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>. <source hwp:id="source-23">Nucleic Acids Res</source>. <volume>46</volume>, <fpage>D1074</fpage>–<lpage>D1082</lpage> (<year>2018</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Poulos, T. L."><surname>Poulos, T.</surname> <given-names>L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Howard A. J."><surname>Howard</surname>, <given-names>A. J.</given-names></string-name> <article-title hwp:id="article-title-25">Crystal structures of metyrapone-and phenylimidazole-inhibited complexes of cytochrome P-450cam</article-title>. <source hwp:id="source-24">Biochemistry</source> <volume>26</volume>, <fpage>8165</fpage>–<lpage>8174</lpage> (<year>1987</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="413237v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Wolber G."><surname>Wolber</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dornhofer, A. A."><surname>Dornhofer, A.</surname> <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Langer T."><surname>Langer</surname>, <given-names>T.</given-names></string-name> <article-title hwp:id="article-title-26">Efficient overlay of small organic molecules using 3D pharmacophores</article-title>. <source hwp:id="source-25">J. Comput. Aided Mol. Des</source>. <volume>20</volume>, <fpage>773</fpage>–<lpage>788</lpage> (<year>2006</year>).</citation></ref></ref-list><sec sec-type="supplementary-material" hwp:id="sec-9"><fig id="figS1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">figS1</object-id><label>Supplementary Figure 1.</label><caption hwp:id="caption-5"><p hwp:id="p-24">An example of identifying a bioactive molecule with the primary target of DNA gyrase and topoisomerase IV inhibition by the minimum structure in 4-pyridone group. Molecule 1 contains five aromatic rings fused to the core (4-pyridone), molecule 2 contains one methyl at X<sub>8</sub>, molecule 4 doesn’t contain -COO or isothiazol-3(2<italic toggle="yes">H</italic>)-one fused to the core at X<sub>3</sub>, molecule 5 contains hydrogen at X<sub>1</sub> and molecule 6 contains one methyl attached to the aromatic ring (phenyl) at X<sub>8</sub> (here X<sub>8</sub> means six-membered aromatic ring fused to the core at X<sub>5</sub>) in position 6. Therefore, the primary target of molecules 1, 2, 4, 5 and 6 is not DNA gyrase and topoisomerase IV inhibition.</p></caption><graphic xlink:href="413237_figS1" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><fig id="figS2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">figS2</object-id><label>Supplementary Figure 2.</label><caption hwp:id="caption-6"><p hwp:id="p-25">An example of identifying a bioactive molecule with the primary target of small ribosomal subunit inhibition by the minimum structure in 2,4(or 5)-diaminocyclohexanol group. Molecules 1, 3, 4, 5 and 6 don’t contain 2,4(or 5)-diaminocyclohexanol (the core). Therefore, the primary target of molecules 1, 3, 4, 5 and 6 is not small ribosomal subunit inhibition.</p></caption><graphic xlink:href="413237_figS2" position="float" orientation="portrait" hwp:id="graphic-6"/></fig><fig id="figS3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">figS3</object-id><label>Supplementary Figure 3.</label><caption hwp:id="caption-7"><p hwp:id="p-26">An example of identifying a bioactive molecule with the primary target of small ribosomal subunit inhibition by the minimum structure in (4a<italic toggle="yes">RS</italic>,5a<italic toggle="yes">RS</italic>)-Sancycline group. Molecules 2, 3, 4, 5 and 6 don’t contain (4a<italic toggle="yes">RS</italic>,5a<italic toggle="yes">RS</italic>)-Sancycline (the core). Therefore, the primary target of molecules 2, 3, 4, 5 and 6 is not small ribosomal subunit inhibition.</p></caption><graphic xlink:href="413237_figS3" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><fig id="figS4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">figS4</object-id><label>Supplementary Figure 4.</label><caption hwp:id="caption-8"><p hwp:id="p-27">An example of identifying a bioactive molecule with the primary target of large ribosomal subunit inhibition by the minimum structure in cytosine group. Molecules 3 and 5 don’t contain cytosine (the core) and molecules 1, 4 and 6 don’t contain at least one of the following components including 5-amino-5,6-dihydro-2<italic toggle="yes">H</italic>-pyran-2-yl, 5-aminotetrahydro-2<italic toggle="yes">H</italic>-pyran-2-yl or 4-formamidobenzoyl. Therefore, the primary target of molecules 1, 3, 4, 5 and 6 is not large ribosomal subunit inhibition.</p></caption><graphic xlink:href="413237_figS4" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><fig id="figS5" position="float" fig-type="figure" orientation="portrait" hwp:id="F5" hwp:rev-id="xref-fig-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">figS5</object-id><label>Supplementary Figure 5.</label><caption hwp:id="caption-9"><p hwp:id="p-28">An example of identifying a bioactive molecule with the primary target of large ribosomal subunit inhibition by the minimum structure in 3-glutarimidyl group. Molecules 2, 3, 4 and 5 don’t contain 3-glutarimidyl (the core) and molecule 1 contains components other than hydrogen at X<sub>1</sub>, X<sub>3</sub> and X<sub>5</sub>. Furthermore, molecule 1 contains components without -OH or -CO at X<sub>4</sub>. Therefore, the primary target of molecules 1, 2, 3, 4 and 5 is not large ribosomal subunit inhibition.</p></caption><graphic xlink:href="413237_figS5" position="float" orientation="portrait" hwp:id="graphic-9"/></fig><fig id="figS6" position="float" fig-type="figure" orientation="portrait" hwp:id="F6" hwp:rev-id="xref-fig-6-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">figS6</object-id><label>Supplementary Figure 6.</label><caption hwp:id="caption-10"><p hwp:id="p-29">An example of identifying a bioactive molecule with the primary target of large ribosomal subunit inhibition by the minimum structure in (1<italic toggle="yes">R</italic>)-propanol group. Molecules 1, 2, 3 and 6 don’t contain (1<italic toggle="yes">R</italic>)-propanol (the core) and molecule 5 doesn’t contain -NCO or -NSO<sub>2</sub> at X<sub>2</sub>. Therefore, the primary target of molecules 1, 2, 3, 5 and 6 is not large ribosomal subunit inhibition.</p></caption><graphic xlink:href="413237_figS6" position="float" orientation="portrait" hwp:id="graphic-10"/></fig><fig id="figS7" position="float" fig-type="figure" orientation="portrait" hwp:id="F7" hwp:rev-id="xref-fig-7-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS7</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">figS7</object-id><label>Supplementary Figure 7.</label><caption hwp:id="caption-11"><p hwp:id="p-30">An example of identifying a bioactive molecule with the primary target of sterol 14α-demethylase inhibition by the minimum structure in imidazol-1-yl group. Molecules 1 and 2 contain a fused aromatic ring but these molecules don’t have an aromatic ring with a halogen in position 2 or 4, molecule 3 has a carbanilate, molecule 4 doesn’t contain a hydrophobic group (directly or indirectly) at X<sub>1</sub> and molecule 6 contains an imidazol-1-yl at one end of the molecule and a carboxylate (-COO) at the other end. Therefore, the primary target of molecules 1, 2, 3, 4 and 6 is not sterol 14α-demethylase inhibition.</p></caption><graphic xlink:href="413237_figS7" position="float" orientation="portrait" hwp:id="graphic-11"/></fig><fig id="figS8" position="float" fig-type="figure" orientation="portrait" hwp:id="F8" hwp:rev-id="xref-fig-8-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS8</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">figS8</object-id><label>Supplementary Figure 8.</label><caption hwp:id="caption-12"><p hwp:id="p-31">An example of identifying a bioactive molecule with the primary target of sterol 14α-demethylase inhibition by the minimum structure in 1,2,4-triazol-1-yl group. Molecule 1 contains components other than hydrogen at X<sub>3</sub>, molecule 3 has a methylbenzonitrile at X<sub>1</sub>, molecule 4 contains a fused aromatic ring but this molecule doesn’t have an aromatic ring with a halogen in position 2 or 4, molecule 5 contains one atom stereocenter and single (<italic toggle="yes">S</italic>)-enantiomer and molecules 1 and 6 don’t contain a hydrophobic group (directly or indirectly) at X<sub>1</sub>. Therefore, the primary target of molecules 1, 3, 4, 5 and 6 is not sterol 14α-demethylase inhibition.</p></caption><graphic xlink:href="413237_figS8" position="float" orientation="portrait" hwp:id="graphic-12"/></fig><fig id="figS9" position="float" fig-type="figure" orientation="portrait" hwp:id="F9" hwp:rev-id="xref-fig-9-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;413237v1/FIGS9</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F9</object-id><object-id pub-id-type="publisher-id">figS9</object-id><label>Supplementary Figure 9.</label><caption hwp:id="caption-13"><p hwp:id="p-32">The process for predicting the primary target from chemical structure based on the minimum structure in a hypothetical example. Molecule 1 is used as the query molecule. Seven structurally related molecules to molecule 1 are found by similarity searching. Since the primary target of the query molecule (molecule 1) is unknown, information on the primary target, structure-activity relationship and pharmacophore are collected for the eight structurally related molecules. Then we consider the following assumptions:</p><p hwp:id="p-33">Molecules 3 and 4 have the primary target of Y. Molecule 3 consists of a square attached to a pentagon with two double bonds, and molecule 4 consists of a triangle attached to a pentagon with two double bonds. Based on information on the structure-activity relationship of molecule 3, the double bonds on the pentagon with two double bonds (cyclopentadiene) must not be reduced. Therefore, the core of these two molecules is the common and important part, named the pentagon with two double bonds (cyclopentadiene). The core of molecules 3 and 4 in the presence of square and triangle is attributed to the pentagon with two double bonds. As a result, the pentagon with two double bonds has priority over the square and the triangle in expressing the primary target of the molecule.</p><p hwp:id="p-34">Molecules 5 and 7 have the primary target of Z. Molecule 5 consists of a square attached to a six-membered aromatic ring (benzene) and a pentagon with two double bonds (cyclopentadiene), and molecule 7 consists of a triangle attached to a five-membered aromatic ring (pyrrole) and a square. Based on information on the structure-activity relationship of molecule 7, the aromatic ring plays an important role in the activity. Therefore, the core of these two molecules is the common and important part, named the aromatic ring (the aromatic ring in molecules 5 and 7 is characterized by LigandScout with AR). There is the pentagon with two double bonds in molecules 3, 4 and 5, but the core of molecule 5 is attributed to the aromatic ring. As a result, the aromatic ring has priority over the pentagon with two double bonds (cyclopentadiene) in expressing the primary target of the molecule.</p><p hwp:id="p-35">Molecules 2 and 6 have the primary target of X. Molecule 2 consists of a triangle attached to a square, and molecule 6 consists of a triangle attached to two squares. Because there is no molecule with the primary target of X having the square or the triangle alone, so the core of these two molecules is the common part, named the triangle attached to the square. The triangle attached to the square is also present in molecule 7, but the core of this molecule is attributed to the aromatic ring. As a result, the aromatic ring has priority over the triangle attached to the square in expressing the primary target of the molecule.</p><p hwp:id="p-36">Molecules 1 and 8 have an unknown target. Molecule 1 consists of a square attached to a triangle and a pentagon, and molecule 8 consists of a square attached to two triangles. There is also a triangle attached to a square (or a square attached to a triangle) in molecules 2, 6 and 7. In addition, the results showed that the aromatic ring and possibly the pentagon with two double bonds (cyclopentadiene) have priority over the triangle attached to the square in expressing the primary target of the molecule, but molecules 1 and 8 don’t contain any the aromatic ring or the pentagon with two double bonds. Therefore, the core of molecules 1 and 8 consists of the triangle attached to the square (cyclopropylcyclobutane) and the peripheral part does not consist the aromatic ring and the pentagon with two double bonds (cyclopentadiene). As a result, the primary target of molecules 1 and 8 is identical to the primary target of their neighbor molecules, named molecules 2 and 6, and the primary target of the two molecules is predicted X.</p></caption><graphic xlink:href="413237_figS9" position="float" orientation="portrait" hwp:id="graphic-13"/></fig></sec><glossary hwp:id="glossary-1"><title hwp:id="title-11">Abbreviations</title><def-list hwp:id="def-list-1"><def-item hwp:id="def-item-1"><term hwp:id="term-1">AR</term><def hwp:id="def-1"><p hwp:id="p-37">aromatic ring</p></def></def-item><def-item hwp:id="def-item-2"><term hwp:id="term-2">H</term><def hwp:id="def-2"><p hwp:id="p-38">hydrophobic interaction</p></def></def-item><def-item hwp:id="def-item-3"><term hwp:id="term-3">HBD</term><def hwp:id="def-3"><p hwp:id="p-39">hydrogen bond donor</p></def></def-item></def-list></glossary></back></article>
